CVS Pharmacies Face $1M Fine for Recordkeeping Violations

CVS Pharmacies Face $1M Fine for Recordkeeping Violations

Birmingham, AL – In a shocking blow to the retail pharmacy giant, CVS Pharmacy, Inc. has agreed to pay a $1 million fine for violating the federal Controlled Substances Act and its implementing regulations at its locations throughout the Northern District of Alabama.

According to sources, an investigation by the Drug Enforcement Administration (DEA) found widespread recordkeeping violations at CVS Pharmacy locations throughout the district. The violations, which occurred prior to July 29, are believed to have compromised the security of controlled substances and undermined the public’s trust in the pharmacy chain.

“Our office is committed to ensuring total compliance with the Controlled Substances Act and we will vigorously enforce violations wherever we find them,” said Assistant U.S. Attorney Jay Saxon, who handled the case. “All DEA registrants should remember that DEA licensure is a privilege; it is not a right. Where that privilege is abused, the Justice Department will take all necessary action to ensure that it is revoked,” he said.

CVS Pharmacy, which operates over 100 retail stores in the Northern District of Alabama, is registered separately with the DEA and is assigned a unique DEA registration number that authorizes it to dispense controlled substances pursuant to the provisions of the Controlled Substances Act. The pharmacy chain’s recordkeeping failures, which were uncovered by the DEA investigation, have raised serious concerns about the security of controlled substances and the public’s safety.

“The misuse of prescription painkillers is a public health crisis in the state of Alabama,” said DEA Special Agent in Charge Stephen G. Azzam. “DEA registrants have a responsibility to handle controlled substances in compliance with the Controlled Substances Act. DEA has an obligation to improve public health and safety, and we are committed to working with our law enforcement and regulatory partners to ensure that these rules and regulations are followed.”

The $1 million fine, which is the largest civil fine paid in Alabama for a DEA registrant, is a stark reminder of the consequences of violating the Controlled Substances Act. The Justice Department will continue to actively monitor compliance with the Act by CVS and other DEA registrants throughout the Northern District of Alabama.

CVS Pharmacy has agreed to pay the $1 million fine, which covers all recordkeeping violations discovered in the Northern District of Alabama prior to July 29, the effective date of the settlement agreement. The pharmacy chain’s executives have promised to take steps to prevent similar violations in the future and to ensure the security of controlled substances at its locations throughout the district.

The DEA and Assistant U.S. Attorney Jay Saxon investigated and handled the case, which has sent shockwaves through the retail pharmacy industry. The case serves as a stark reminder of the importance of compliance with the Controlled Substances Act and the consequences of violating it.

CVS Pharmacy’s recordkeeping failures have raised serious concerns about the security of controlled substances and the public’s safety. The pharmacy chain’s executives have promised to take steps to prevent similar violations in the future and to ensure the security of controlled substances at its locations throughout the district.

The Justice Department’s vigorous enforcement of the Controlled Substances Act has sent a message to the retail pharmacy industry: compliance is not optional. DEA registrants who fail to comply with the Act will face serious consequences, including fines, penalties, and even license revocation.

MORE FEDERAL CRIME NEWS

Drug Trafficking

Dazaughn Ellis West, Fentanyl Trafficking, Minnesota 2023

Aug 1, 2024

Drug Trafficking

Darius Dashawn Wade, Aiding and Abetting the Distribution of Fentanyl, West Virginia 2021

Sep 7, 2021

Drug Trafficking

Troy Roberts, Crack and Heroin Trafficking, Maine 2020

May 5, 2022

Drug Trafficking

Kelvin Johnson, Distribution of Heroin, West Virginia 2016

Apr 18, 2017